Notice Number: NOT-AI-16-055
Release Date: May 27, 2016
The purpose of this announcement is to inform potential applicants of a clarification regarding the Funding Opportunity Announcement (FOA) RFA-AI-16-001 titled "Immunity in Neonates and Infants" (U01). When this FOA was originally released, the effects of Zika virus infection on the developing fetus, or possible effects on neonatal/infant immunity, were not appreciated.
Applications that include studies of neonates (0-28 days), infants (29 days-1 year) or relevant animal models infected with Zika virus in utero or postnatally are responsive to this FOA. Hypothesis-based studies designed to understand the impact of Zika virus infection on the developing immune system, including characterization of immune responses to childhood vaccines post-Zika virus infection are encouraged.
Potential applicants conducting Zika virus research outside the scope of the this FOA should consult the NIAID Funding Opportunities website https://www.niaid.nih.gov/researchfunding/ann/pages/opps.aspx and the NIH Guide for Grants and Contracts https://grants.nih.gov/funding/about-nih-guide-to-grants-and-contracts.htm.
Please direct all inquiries to:
Mercy PrabhuDas, PhD, MBA
National Institute of Allergy and Infectious Diseases (NIAID)